NCT05625295 (TeleDermaSA) is a clinical trial of data collection protocol in clinical history in Teledermatology, sponsored by Fundacion para la Investigacion y Formacion en Ciencias de la Salud.

Who is sponsoring NCT05625295?

NCT05625295 is sponsored by Fundacion para la Investigacion y Formacion en Ciencias de la Salud.

What drugs are being tested in NCT05625295?

Interventions in NCT05625295: data collection protocol in clinical history.

What condition does NCT05625295 study?

NCT05625295 studies Teledermatology, Primary Care.

Is NCT05625295 still recruiting?

NCT05625295 is currently completed. Last updated 20 July 2023.

Last reviewed 2023-07-20 · How we verify

NCT05625295: TeleDermaSA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tele-dermatology Non-presential (TeleDermaSA)

Completed Last updated 20 July 2023

What this trial tests

trial testing data collection protocol in clinical history in Teledermatology in 1,000 participants. Completed in 1 July 2023.

Timeline

1 November 2022

Primary endpoint
1 June 2023

1 July 2023

Quick facts

Lead sponsor	Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 November 2022
Primary completion	1 June 2023
Estimated completion	1 July 2023
Sites	1 location across Spain

Drugs / interventions tested

data collection protocol in clinical history

Conditions studied

Teledermatology — all drugs for Teledermatology →
Primary Care — all drugs for Primary Care →

Sponsor

Fundacion para la Investigacion y Formacion en Ciencias de la Salud

Who can join

Adults 18 to 80, any sex, with Teledermatology or Primary Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate the implementation of the Non-Face-to-Face Interconsultation of dermatology since it began to be used in August 2020 until August 2022 in the province of Salamanca (Spain)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Store-and-forward teledermatology in a Spanish health area significantly increases access to dermatology expertise.
Sánchez-Martín E, Moreno-Sánchez I, Morán-Sánchez M, Pérez-Martín M, et al · · 2024 · cited 3× · PMID 38914974 · DOI 10.1186/s12875-024-02479-1

Verify or expand the search:

Other Fundacion para la Investigacion y Formacion en Ciencias de la Salud trials

Trials by the same sponsor.

NCT05866133 — Relationship of Addictions to Obesity, Physical Activity and Vascular Ageing in Young Adults · unknown
NCT05819840 — Vascular Structure, Vascular Function and Vascular Aging in Adults Diagnosed With Persistent COVID · unknown
NCT05912088 — Elderly Falls Prevention With sLiFE Program in Primary Care · NA · unknown
NCT05986110 — Analysis of the Results Obtained in the Regular Clinical Practice of a Clinical Ultrasound Classroom For Primary Care Ph · NA · unknown
NCT05506436 — Evaluation of an Implementation Strategy of mHealth Intervention to Promote Healthy Lifestyles (E-VIDAPP Pilot Study) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05625295 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Last refreshed: 20 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05625295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing